TOMI ENVIRONMENTAL SOLUTIONS (TOMZ)

US8900232039 - Common Stock

0.7752  +0.01 (+0.68%)

After market: 0.74 -0.04 (-4.54%)

Fundamental Rating

3

Overall TOMZ gets a fundamental rating of 3 out of 10. We evaluated TOMZ against 83 industry peers in the Commercial Services & Supplies industry. The financial health of TOMZ is average, but there are quite some concerns on its profitability. While showing a medium growth rate, TOMZ is valued expensive at the moment.



1

1. Profitability

1.1 Basic Checks

In the past year TOMZ has reported negative net income.
In the past year TOMZ has reported a negative cash flow from operations.
In the past 5 years TOMZ reported 4 times negative net income.
TOMZ had negative operating cash flow in 4 of the past 5 years.

1.2 Ratios

The Return On Assets of TOMZ (-19.63%) is worse than 87.95% of its industry peers.
Looking at the Return On Equity, with a value of -33.27%, TOMZ is doing worse than 78.31% of the companies in the same industry.
Industry RankSector Rank
ROA -19.63%
ROE -33.27%
ROIC N/A
ROA(3y)-23.78%
ROA(5y)-14.62%
ROE(3y)-32.84%
ROE(5y)-64.74%
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

TOMZ has a better Gross Margin (60.08%) than 96.39% of its industry peers.
In the last couple of years the Gross Margin of TOMZ has remained more or less at the same level.
The Profit Margin and Operating Margin are not available for TOMZ so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 60.08%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.99%
GM growth 5Y0.85%

4

2. Health

2.1 Basic Checks

TOMZ does not have a ROIC to compare to the WACC, probably because it is not profitable.
TOMZ has more shares outstanding than it did 1 year ago.
The number of shares outstanding for TOMZ has been increased compared to 5 years ago.
Compared to 1 year ago, TOMZ has a worse debt to assets ratio.

2.2 Solvency

TOMZ has an Altman-Z score of -3.16. This is a bad value and indicates that TOMZ is not financially healthy and even has some risk of bankruptcy.
TOMZ has a worse Altman-Z score (-3.16) than 90.36% of its industry peers.
TOMZ has a Debt/Equity ratio of 0.32. This is a healthy value indicating a solid balance between debt and equity.
Looking at the Debt to Equity ratio, with a value of 0.32, TOMZ is in the better half of the industry, outperforming 63.86% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.32
Debt/FCF N/A
Altman-Z -3.16
ROIC/WACCN/A
WACC8.85%

2.3 Liquidity

TOMZ has a Current Ratio of 4.13. This indicates that TOMZ is financially healthy and has no problem in meeting its short term obligations.
TOMZ has a better Current ratio (4.13) than 87.95% of its industry peers.
TOMZ has a Quick Ratio of 2.06. This indicates that TOMZ is financially healthy and has no problem in meeting its short term obligations.
With an excellent Quick ratio value of 2.06, TOMZ belongs to the best of the industry, outperforming 81.93% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 4.13
Quick Ratio 2.06

5

3. Growth

3.1 Past

The Earnings Per Share has grown by an nice 13.33% over the past year.
TOMZ shows a decrease in Revenue. In the last year, the revenue decreased by -5.01%.
TOMZ shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 5.68% yearly.
EPS 1Y (TTM)13.33%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%100%
Revenue 1Y (TTM)-5.01%
Revenue growth 3Y-33.52%
Revenue growth 5Y5.68%
Sales Q2Q%72.94%

3.2 Future

TOMZ is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 32.21% yearly.
Based on estimates for the next years, TOMZ will show a very strong growth in Revenue. The Revenue will grow by 34.91% on average per year.
EPS Next Y70%
EPS Next 2Y45.6%
EPS Next 3Y41.61%
EPS Next 5Y32.21%
Revenue Next Year16.44%
Revenue Next 2Y26.84%
Revenue Next 3Y38.25%
Revenue Next 5Y34.91%

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.

2

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for TOMZ. In the last year negative earnings were reported.
Based on the Price/Forward Earnings ratio of 38.00, the valuation of TOMZ can be described as expensive.
TOMZ's Price/Forward Earnings ratio is in line with the industry average.
TOMZ's Price/Forward Earnings ratio indicates a rather expensive valuation when compared to the S&P500 average which is at 22.83.
Industry RankSector Rank
PE N/A
Fwd PE 38

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
TOMZ's earnings are expected to grow with 41.61% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y45.6%
EPS Next 3Y41.61%

0

5. Dividend

5.1 Amount

No dividends for TOMZ!.
Industry RankSector Rank
Dividend Yield N/A

TOMI ENVIRONMENTAL SOLUTIONS

NASDAQ:TOMZ (12/20/2024, 8:00:01 PM)

After market: 0.74 -0.04 (-4.54%)

0.7752

+0.01 (+0.68%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCommercial & Professional Services
GICS IndustryCommercial Services & Supplies
Earnings (Last)10-30 2024-10-30/amc
Earnings (Next)N/A N/A
Inst Owners4.84%
Inst Owner Change10.27%
Ins Owners102.73%
Ins Owner Change0%
Market Cap15.52M
Analysts82.86
Price Target3.57 (360.53%)
Short Float %0.04%
Short Ratio0.22
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)-15.65%
Min Revenue beat(2)-35.57%
Max Revenue beat(2)4.27%
Revenue beat(4)1
Avg Revenue beat(4)-34.14%
Min Revenue beat(4)-57.59%
Max Revenue beat(4)4.27%
Revenue beat(8)1
Avg Revenue beat(8)-34.15%
Revenue beat(12)2
Avg Revenue beat(12)-31.52%
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-50%
EPS NY rev (1m)0%
EPS NY rev (3m)-150%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-42.85%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-27.89%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 38
P/S 1.89
P/FCF N/A
P/OCF N/A
P/B 2.11
P/tB 2.48
EV/EBITDA N/A
EPS(TTM)-0.13
EYN/A
EPS(NY)0.02
Fwd EY2.63%
FCF(TTM)-0.15
FCFYN/A
OCF(TTM)-0.13
OCFYN/A
SpS0.41
BVpS0.37
TBVpS0.31
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -19.63%
ROE -33.27%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 60.08%
FCFM N/A
ROA(3y)-23.78%
ROA(5y)-14.62%
ROE(3y)-32.84%
ROE(5y)-64.74%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.99%
GM growth 5Y0.85%
F-Score2
Asset Turnover0.66
Health
Industry RankSector Rank
Debt/Equity 0.32
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 71.45%
Cap/Sales 2.77%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 4.13
Quick Ratio 2.06
Altman-Z -3.16
F-Score2
WACC8.85%
ROIC/WACCN/A
Cap/Depr(3y)107.87%
Cap/Depr(5y)83.89%
Cap/Sales(3y)4.69%
Cap/Sales(5y)4.05%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)13.33%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%100%
EPS Next Y70%
EPS Next 2Y45.6%
EPS Next 3Y41.61%
EPS Next 5Y32.21%
Revenue 1Y (TTM)-5.01%
Revenue growth 3Y-33.52%
Revenue growth 5Y5.68%
Sales Q2Q%72.94%
Revenue Next Year16.44%
Revenue Next 2Y26.84%
Revenue Next 3Y38.25%
Revenue Next 5Y34.91%
EBIT growth 1Y26.44%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year89.82%
EBIT Next 3Y64.13%
EBIT Next 5Y49.55%
FCF growth 1Y-114.47%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-189.22%
OCF growth 3YN/A
OCF growth 5YN/A